A real GLP-1 under $150 a month exists in 2026. Six of them, actually. But every single one carries fine print the ads skip, and at this price tier the fine print is the whole story. Five of the six sell compounded semaglutide or tirzepatide — drugs that are not FDA-approved — and the sixth hides half its real cost in a membership fee.
Here’s the pattern we found. The $79 price is a first-month promo that becomes $199. The $89 price draws billing complaints and an F from the BBB. One $99 price demands $1,188 upfront. The $149 price sits on top of a second $149 charge. This page ranks all six options by entry price and tells you exactly what each dollar figure hides — renewal jumps, refund traps, FDA warning letters, all of it.
1. Noom Med — $79 to Start, $199 to Stay
Score: 8.7 (Very Good). Noom Med owns the cheapest first month on this list. Its Microdose GLP-1Rx program costs $79 for the first 4-week supply of low-dose compounded semaglutide. That single price includes the medication, clinician care, and Noom’s full behavior-change coaching app — the thing the company built its name on since 2008.
Now the fine print. After month one, the price becomes $199 per month, billed quarterly. That’s a 152% jump. Stranger still, Noom’s own product page showed a $179/month renewal rate the same week its pricing hub showed $199 — the company’s pages contradicted each other in July 2026. Either way, you will never pay $79 twice.
Be clear on what you’re buying: compounded semaglutide is not FDA-approved. Noom says its supply comes from an FDA-regulated 503B outsourcing facility, but the FDA has not reviewed any compounded GLP-1 for safety, effectiveness, or quality. The compounded plans also skip three states — Alabama, Louisiana, and Mississippi are out.
The trust picture is stronger than most budget rivals. Noom holds a BBB A+ rating, accredited since 2021, and offers a Taper-Off Guarantee: a free year of Noom or medication discounts if you regain weight within 18 months after completing a 12-month course with its taper protocol.
Pricing Structure
| Plan | First month | Then |
|---|---|---|
| Microdose GLP-1Rx | $79 | $199/mo, billed quarterly |
| GLP-1Rx (compounded semaglutide) | $129 | $249/mo, billed quarterly |
| GLP-1Rx Plus (compounded tirzepatide) | $149 | $299/mo, billed quarterly |
| Metformin pill plan | $69 | $99/mo, billed quarterly |
The billing rhythm matters as much as the rate. After the promo month, charges land in $537 to $837 lump sums every 12 weeks depending on plan. Budget for the quarter, not the month.
Pros & Cons
Pros:
- Cheapest entry on this page: $79 for the first 4-week supply
- Medication, clinician care, and coaching bundled in one flat price
- BBB A+, accredited since 2021; company operating since 2008
- Taper-Off Guarantee covers regain within 18 months after a 12-month course
Cons:
- 152% price jump after month one, to $199/mo
- Quarterly lump billing of $537+ once the promo ends
- Noom’s own pages showed conflicting renewal rates ($179 vs $199) in July 2026
- Not available in AL, LA, or MS; no published refund policy beyond cancel anytime
2. altRx — $89 on Paper, an F From the BBB
Score: 6.0 (Fair). altRx advertises the lowest flat monthly rate here: $89/month for compounded semaglutide, shown as marked down from $199. Compounded tirzepatide runs $149/month. A 12-month commitment cuts semaglutide to $75/month. It ships to all 50 states, charges no membership fee, and includes free delivery in about 4 to 5 business days.
So why does it score 6.0? The receipts. altRx carries a BBB F rating with 39 complaints the company never answered — and its BBB file only opened in May 2026. A recent Trustpilot snapshot showed 2.5/5 with 51% one-star reviews, per third-party review data, and Trustpilot noted it removed fake reviews for this company. The most repeated allegation is the one that matters most on a budget page: customers say they signed up at $89 and were charged $189 to $199 in later billing cycles. That directly contradicts the site’s no-price-hike promise.
There’s regulatory history too. In June 2026, the FDA issued a warning letter to Trinity HealthCare Supply, LLC dba altRx over misleading claims about compounded semaglutide and tirzepatide on the altRx site. Those drugs are not FDA-approved — altRx’s own disclaimer says the FDA has not evaluated them. And refunds are nearly off the table: once an order is approved and processing, no refunds, with narrow exceptions inside a 28-day window.
One genuine transparency point: altRx publicly names its four 503A compounding pharmacy partners — Belmar, Strive, Epiq Scripts, and Casa Pharma Rx. Most competitors won’t even do that.
Pricing Structure
| Product | Advertised price | Fine print |
|---|---|---|
| Compounded semaglutide | $89/mo | Complaints report $189-$199 later charges |
| Compounded tirzepatide | $149/mo | Same flat-dose claim applies |
| 12-month semaglutide plan | $75/mo | Year-long commitment |
| Brand-name Ozempic | $1,149/mo | Cash pay; no insurance accepted |
Pros & Cons
Pros:
- Lowest advertised flat rate on this page: $89/mo at every dose
- Names all four compounding pharmacies — rare transparency
- All 50 states, no membership fee, free shipping
- 12-month plan drops semaglutide to $75/mo
Cons:
- BBB F rating with 39 unanswered complaints on a file opened May 2026
- Recurring user reports of $189-$199 charges after the $89 sign-up
- June 2026 FDA warning letter over misleading GLP-1 marketing
- No refunds once an order is approved, processing, or shipped
3. Trinity Meds — Flat $99, but a 2.1 on Trustpilot
Score: 6.8 (Fair). Trinity Meds sells compounded semaglutide at $99/month with the same price at every dose — no prepay required. Multi-month plans push it lower: $94/month for 3 months, $89 for 6, and $84/month on a 12-month plan. Compounded tirzepatide is $149/month, down to $125 on the annual plan. The price covers the consult, prescription, shipping, and check-ins, with FSA eligibility and buy-now-pay-later on offer.
The catch count is high. Trustpilot scores Trinity Meds 2.1/5 from 119 reviews, with 65% one-star — complaints cite slow support, charges after cancellation, and billing for prescriptions that were never approved. The terms are unforgiving: consult fees are non-refundable, all prescription sales are final, and every plan auto-renews until you explicitly cancel.
The pricing story doesn’t fully agree with itself either. The main site says $99 and $149; the company’s own go.trinitymeds.com funnel listed $159 semaglutide and $259 tirzepatide for the same drugs the same week, plus brand-name Ozempic at $999/month. Screenshot the price you actually sign up at.
One more connection worth knowing. Trinity Meds’ press materials identify its operator as Trinity Healthcare Supply, LLC — the same legal entity named in the FDA’s June 2026 warning letter over the affiliated altRx brand’s website. The letter doesn’t mention trinitymeds.com, but the shared LLC is a fact we weight. As everywhere on this page: the compounded drugs are not FDA-approved, and the site says so.
Pricing Structure
| Term | Semaglutide | Tirzepatide |
|---|---|---|
| Monthly | $99/mo | $149/mo |
| 3-month | $94/mo | $144/mo |
| 6-month | $89/mo | $130/mo |
| 12-month | $84/mo | $125/mo |
The funnel page adds a first-order promo of $100 off — and warns the end-to-end process typically takes about 1.5 to 3 weeks to first delivery.
Pros & Cons
Pros:
- Flat $99/mo at every dose with no upfront prepay required
- 12-month plan cuts semaglutide to $84/mo
- Names all four dispensing pharmacies, with phone numbers
- FSA-eligible; buy-now-pay-later financing available
Cons:
- Trustpilot 2.1/5 with 65% one-star reviews
- All prescription sales final; consult fees non-refundable; auto-renewal until cancelled
- Company pages show conflicting prices ($99 vs $159 for the same drug)
- Operator LLC matches the recipient of a June 2026 FDA warning letter
4. bmiMD — $99/Month That Costs $1,188 Today
Score: 8.2 (Very Good). bmiMD is the best-documented operator in the sub-$100 tier. Its $99/month compounded semaglutide price is real — but only on the 12-month plan, which bills $1,188 upfront every 12 months. Month-to-month costs $129. Compounded tirzepatide starts at $139/month on the annual plan ($1,638 billed at once), and new members can grab a first month of tirzepatide for $89.50 on the current promo.
Why does it outscore altRx, Trinity, and Sprout? Track record. Trustpilot shows roughly 4 stars across 800+ reviews, per July 2026 third-party snapshots — a different universe from the 2.1s and 2.2s elsewhere on this page. bmiMD also publishes quality-testing claims most rivals don’t: potency verified within ±10% every 3 to 6 months, USP 797 sterility, and endotoxin testing through FDA- and DEA-registered third-party labs. And the checkout is fairer than most — your card is authorized but not charged until a provider approves you, with a 100% refund if you’re found ineligible.
Still, read the exit terms before wiring a year’s money. There’s a $50 non-refundable cancellation fee if you cancel after intake approval but before pharmacy processing, and all sales are final once the pharmacy processes your order — no refunds for partially used subscription periods. The BBB rates bmiMD C+ with 38 complaints on file. Its compounding pharmacies are unnamed, and there is no brand-name option at all: this is a compounded-only shop, and compounded GLP-1s are not FDA-approved.
Pricing Structure
| Plan | Monthly rate | What you actually pay |
|---|---|---|
| Semaglutide, 12-month | $99/mo | $1,188 billed every 12 months |
| Semaglutide, 6-month | $109/mo | $654 upfront |
| Semaglutide, 3-month | $119/mo | $357 upfront |
| Semaglutide, month-to-month | $129/mo | $129 each month |
| Tirzepatide, 12-month | $139/mo | $1,638 billed at once |
Pros & Cons
Pros:
- Genuinely flat pricing at every dose; free shipping on subscriptions
- Roughly 4-star Trustpilot across 800+ reviews, per third-party snapshots
- No charge until provider approval; 100% refund if ineligible
- Published potency, sterility, and endotoxin testing claims via third-party labs
Cons:
- The $99 headline requires $1,188 paid upfront for 12 months
- $50 cancellation fee in the intake-to-pharmacy window; all sales final after processing
- BBB C+, not accredited, 38 complaints on file
- Pharmacies unnamed; compounded-only lineup with no FDA-approved option
5. Sprout Health — $149 With an FDA Letter in Its File
Score: 6.4 (Fair). Sprout Health advertises compounded semaglutide starting at $149/month, with a 3-month supply promoted at $465 — the regular price is $615, which works out to about $205/month once the promo ends. Compounded tirzepatide lists from $199/month. The site makes an unusually explicit written promise: the price never increases from the agreed monthly payment, even if your dose goes up. There’s no membership or consult fee, and delivery typically runs 5 to 7 business days after prescription.
The history is the problem. In September 2025, the FDA issued Sprout Health warning letter #715879 for claiming its compounded GLP-1s were FDA-approved. They were not — no compounded semaglutide or tirzepatide is FDA-approved, and the site now discloses exactly that. The record since hasn’t recovered: a BBB F rating with 63 complaints, 32 of them unanswered, as of July 2026, and a Trustpilot around 2.2/5 with 84% one-star reviews, per third-party search data. BBB complaints describe charges landing within minutes of applying, before any consultation, and support that can’t be reached to cancel.
Sprout is also young — in business since January 2025 — and doesn’t name its compounding pharmacies or their 503A/503B status. It won’t ship compounded meds to Arkansas, Kansas, or New Mexico. One genuine differentiator: a sublingual (under-the-tongue) semaglutide option for people who won’t do injections. Shipped medication cannot be returned.
Pricing Structure
| Product | Advertised | Notes |
|---|---|---|
| Compounded semaglutide | From $149/mo | 3-month promo $465; regular $615 |
| Compounded tirzepatide | From $199/mo | Regular price listed at $349 |
| Brand-name Wegovy | From $1,799/mo | Cash pay |
| Brand-name Zepbound | From $1,999/mo | Cash pay |
Displayed prices are promotional and have shifted over time — third-party reviews cite earlier figures of $199 for the first month, then $249/month. Treat any Sprout price as a snapshot, not a contract.
Pros & Cons
Pros:
- Written flat-price guarantee: no increase when your dose increases
- Sublingual semaglutide option — no needles required
- No membership or consultation fees; refund if found medically ineligible
- Prescription-to-delivery generally within 5 to 7 business days
Cons:
- September 2025 FDA warning letter for falsely calling compounded GLP-1s FDA-approved
- BBB F rating; 63 complaints with 32 unanswered
- Trustpilot about 2.2/5 with 84% one-star, per third-party data
- Pharmacies unnamed; no shipping to AR, KS, or NM; shipped meds non-returnable
6. Hers — $149 Pills Plus a $149 Membership: Do the Math
Score: 8.5 (Very Good). Hers is the only brand on this page selling FDA-approved medication near the $150 line. Its drug-pricing page lists the Wegovy pill, Ozempic pill, and Foundayo pill from $149/month — real brand-name GLP-1 medication, not a compounded copy, at a fraction of the $1,899/month retail Mounjaro and Zepbound pens listed on the same page.
Now do the math the homepage doesn’t. Medication pricing requires an active Hers Weight Loss Membership: $39 the first month, then $149/month, auto-renewing and billed separately. Per the official site, the membership does not include or guarantee a prescription. So the cheapest realistic first month lands around $193 including $5 shipping, and roughly $303/month ongoing, per third-party pricing reports from July 2026. That’s double the sticker — for the FDA-approved product, it may still be the best value here, but it is not a $149 program.
Two more flags. All prices are from prices that rise with dose, and Hers does not publish full dose-by-dose rates. And Hers has its own regulatory scar: a September 2025 FDA warning letter over misleading compounded semaglutide marketing, followed by a Novo Nordisk patent lawsuit in February 2026, per news reports. Since then the company has pivoted hard to FDA-approved brand-name drugs, limiting compounded product to medical necessity. The BBB rates it A+, and it operates in all 50 states with asynchronous reviews typically inside 24 hours.
Pricing Structure
| Item | Price |
|---|---|
| Wegovy, Ozempic, or Foundayo pill | From $149/mo |
| Wegovy pen or Ozempic injection | From $199/mo |
| Zepbound vial or KwikPen | From $299/mo |
| Required membership | $39 first month, then $149/mo |
| Realistic ongoing total | About $303/mo, per third-party pricing reports |
Refunds are tight: initial medication orders can only be cancelled within 48 hours, shipped orders are non-refundable, and cancelling medication does not cancel the membership.
Pros & Cons
Pros:
- Only FDA-approved, brand-name option on this list at the $149 tier
- Pill and injectable formats; all 50 states; provider review typically within 24 hours
- BBB A+; operated by NYSE-listed Hims & Hers
- Zepbound formats from $299/mo versus the $1,899/mo retail pens it lists
Cons:
- Mandatory $149/mo membership pushes real cost to about $303/mo
- From-pricing rises with dose; full dose-by-dose rates not published
- 48-hour refund window; cancelling medication does not cancel the membership
- September 2025 FDA warning letter over past compounded semaglutide marketing
What Does a GLP-1 Under $150 Actually Buy You?
One of two very different things. Five of the six programs above sell compounded semaglutide or tirzepatide — versions mixed by compounding pharmacies, not made by Novo Nordisk or Eli Lilly. These are not FDA-approved, full stop. The FDA has not reviewed any compounded GLP-1 for safety, effectiveness, or quality, and the agency has publicly warned about dosing errors and adverse events tied to unapproved versions. Whether you can even buy them legally where you live is its own question — our guide to whether compounded GLP-1s are legal walks through it.
The sixth option is different in kind. Hers’ $149 tier buys FDA-approved brand-name pills — the real, agency-reviewed product. You pay for that legitimacy through the $149/month membership, landing around $303/month all-in, per third-party pricing reports. That’s the honest trade at this price point: $89 to $149 for compounded drugs with regulatory question marks, or about $303 real cost for the FDA-approved version. There is no third door in 2026.
Why Do Cheap GLP-1 Prices Jump After Month One?
Because the number in the ad is a customer-acquisition price, not the rate you’ll live with. The evidence is all over this page. Noom’s $79 becomes $199/month — a 152% increase. Sprout’s displayed prices are promotional and have moved over time. altRx customers report $189 to $199 charges after signing at the advertised $89, per BBB and Trustpilot complaints — the single most common grievance in its file.
Before you enter a card number, pin down three things in writing. First, the renewal price after any promo. Second, the billing interval — Noom bills $537+ quarterly, and bmiMD’s $99 rate bills $1,188 annually. Third, the refund policy: four of the six companies here make prescription sales final once the pharmacy moves. Fine print like this is a core input to our scores — see how we rank for the full methodology.
Is the FDA Cracking Down on Budget GLP-1 Sellers?
Yes, and three of the six companies on this page have the letters to prove it. Sprout Health (September 2025) was cited for falsely claiming its compounded drugs were FDA-approved. Hers (September 2025) was cited over misleading compounded semaglutide marketing — part of a wave of 55+ warning letters to compounded GLP-1 sellers announced that month, per industry press reports. And in June 2026, the FDA wrote to Trinity HealthCare Supply, LLC — the entity behind both altRx and, per its own press materials, Trinity Meds — over misleading GLP-1 claims.
The backdrop keeps shifting too. The compounding rules that let this sub-$150 market exist are tied to drug supply and enforcement decisions that changed repeatedly through 2025 and 2026 — Hers, for one, wound down its prepaid compounded plans and now limits compounded semaglutide to medical necessity. Our guide to the 2026 GLP-1 shortage and compounding rules covers what’s still permitted and what’s on borrowed time. If a bargain depends on a legal gray zone, price in the chance it disappears mid-treatment.
How Much Weight Can You Lose on a Budget GLP-1?
The honest answer: the trial data comes from FDA-approved versions only. In the STEP 1 trial, adults taking semaglutide 2.4 mg lost an average of 14.9% of body weight over 68 weeks. In SURMOUNT-1, tirzepatide produced average losses up to 20.9% over 72 weeks at the highest dose. Compounded copies have no equivalent large-scale trials — when a $99 program implies those results, it’s borrowing data from a drug it doesn’t sell.
Pace your expectations by the calendar, not the marketing. Both trials ran well past a year, with doses stepped up gradually along the way. Appetite changes often show up within weeks, but the headline percentages take 12 to 18 months — our guide to how fast GLP-1s work maps the typical timeline. Which leads to the real budget question on a page like this one: multiply the renewal price by 12 before judging any deal. A $79 first month means nothing if month 14 costs $199 and you quit at month 4. The cheapest GLP-1 is the one you can still afford when the promo is a distant memory.